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Introduction {#bcp13662-sec-0005}
============

The escalating number of therapeutic candidates in drug development programs require strategies that optimize the process of clinical development. A common approach is the use of biomarkers in clinical trials. A biomarker is defined as a characteristic that can be objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention [1](#bcp13662-bib-0001){ref-type="ref"}, [2](#bcp13662-bib-0002){ref-type="ref"}. Clinical biomarkers are thought to reflect disease activity and pathophysiology [3](#bcp13662-bib-0003){ref-type="ref"}, [4](#bcp13662-bib-0004){ref-type="ref"}. A useful biomarker in any class has to comply with the following general criteria: (i) there must be a consistent response of the biomarker across studies (preferably from different research groups) and drugs from the same mechanistic class; (ii) the biomarker must respond clearly to therapeutic (not supratherapeutic) doses; (iii) there must be a clear dose‐ or concentration‐response relationship; and (iv) there must a plausible relationship between the biomarker, pharmacology of the drug class and disease pathophysiology [4](#bcp13662-bib-0004){ref-type="ref"}. Validated biomarkers are often being used to guide drug development programmes from human pharmacology studies, i.e. phase 1 trials, to confirmatory trials, i.e. phase 3 studies [2](#bcp13662-bib-0002){ref-type="ref"}. For dermatological diseases the drug developers often rely on clinical efficacy scores, e.g. the Eczema Area and Severity Index (EASI) for atopic dermatitis (AD), Psoriasis Area and Severity Index for psoriasis vulgaris (PV) and inflammatory lesion count for acne vulgaris (AV) or investigator global assessments. However, more objective outcome measures including validated biomarkers would have great added value in this field. One of these potential new biomarkers is the human skin microbiome, which has the potential to monitor disease activity and drug specific (mechanistic) effects.

The human microbiome refers to the combined genomic information of all microbial communities living on or in the human body. Collectively, this encompasses fungi (mycobiota), bacteria (microbiota), viruses, bacteriophage, archaea and protozoa. This, along with the human genome, completes what is now termed the human microbial superorganism [5](#bcp13662-bib-0005){ref-type="ref"}. The skin microbiome harbours vast microbial communities living in a range of both physiologically and topographically distinct niches and microenvironments [6](#bcp13662-bib-0006){ref-type="ref"}, [7](#bcp13662-bib-0007){ref-type="ref"}. Actinobacteria (52%), Firmicutes (24%), Proteobacteria (17%) and Bacteroidetes (7%) are the four most abundant species identified on the skin [8](#bcp13662-bib-0008){ref-type="ref"}. Previous studies have shown that it is not only skin topography that influences microbial colonization, but also a vast range of host‐specific factors including age and sex, and environmental factors such as occupation, clothing choice, antibiotic use, cosmetics, soaps, environmental temperature, humidity, and longitudinal and/or latitudinal variation in UV exposure, which can all contribute to the variability seen in the microbial flora of the skin [9](#bcp13662-bib-0009){ref-type="ref"}, [10](#bcp13662-bib-0010){ref-type="ref"}, [11](#bcp13662-bib-0011){ref-type="ref"}, [12](#bcp13662-bib-0012){ref-type="ref"}, [13](#bcp13662-bib-0013){ref-type="ref"}, [14](#bcp13662-bib-0014){ref-type="ref"}, [15](#bcp13662-bib-0015){ref-type="ref"}. Moreover, changes or aberrations in the skin microbiome have been implicated in the pathophysiology of numerous skin diseases such as AD and AV [16](#bcp13662-bib-0016){ref-type="ref"}.

Several reviews have described the role and impact of skin microbiome on disease [17](#bcp13662-bib-0017){ref-type="ref"}, [18](#bcp13662-bib-0018){ref-type="ref"}, [19](#bcp13662-bib-0019){ref-type="ref"}, [20](#bcp13662-bib-0020){ref-type="ref"}, [21](#bcp13662-bib-0021){ref-type="ref"}, [22](#bcp13662-bib-0022){ref-type="ref"}. However, to date, no structured review has been conducted to evaluate the feasibility, suitability and potential use of the skin microbiome as biomarker for early phase clinical drug development. Therefore, we conducted a systemic literature review with predefined search terms according to the PRISMA guidelines, with focus on six relevant disorders, i.e. AD, seborrhoeic dermatitis and pityriasis capitis (dandruff; SD/PC), AV, hidradenitis suppurativa (HS), PV and ulcus cruris/chronic wounds (UC). In addition, we evaluated and ranked the conditions regarding the potential as clinical biomarker. Lastly, we provided recommendations for prospective microbiome investigations in clinical drug development programmes.

Methods {#bcp13662-sec-0006}
=======

We followed the Preferred Reporting Items for Systematic Reviews and Meta‐analysis (PRISMA) [23](#bcp13662-bib-0023){ref-type="ref"}. In collaboration with a trained librarian from the Leiden University Medical Centre, a structured electronic literature search was composed, using a combination of two main search criteria: microbiome and the targeted skin condition (i.e. AD, SD/PC, HS, AV, UC and PV). For each search term, all relevant keyword variations were used in conjunction with free text word variations. The search strategy was optimized for all consulted databases, taking into account the differences of the various controlled vocabularies, as well as the differences of database‐specific technical variations (e.g. the use of quotation marks). The final search was performed on 29 September 2017, using bibliographic databases including PubMed (incl. MEDLINE), Embase (OVID‐version), Web of Science, Cochrane Library, CENTRAL, Academic Search Premier and ScienceDirect. Animal‐only studies, reviews without original data, non‐English studies and case studies were excluded. Moreover, culture‐based methods were excluded since the objective of this review was to explore the full microbiome profile and relative abundances compared to other genus as biomarker. The remaining studies were fully reviewed. The overall quality of evidence was rated using pre‐defined criteria (group size, type of control, method of sampling, serial sampling available, well defined metadata, analysis method). *Grading of Recommendations Assessment, Development and Evaluation* (GRADE) guidelines were used as guidance for rating the quality of evidence [24](#bcp13662-bib-0024){ref-type="ref"}. This was done by two investigators independently and the final outcome was determined by discussion once discrepancies occurred.

Results {#bcp13662-sec-0007}
=======

The search resulted in 841 titles. After duplicates were removed, 443 papers were screened for inclusion. Four‐hundred‐and‐one manuscripts were excluded based on the exclusion criteria with mostly culture‐based studies that were not eligible. The remaining 42 studies were identified as using nonculture‐based methods to analyse microbiome populations in one of the targeted skin conditions and fully reviewed, Figure [1](#bcp13662-fig-0001){ref-type="fig"}. All 42 were included in the review, the study characteristics can be found in Table [1](#bcp13662-tbl-0001){ref-type="table"}.
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Summary table of the studies included in the review

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source First author, year \[ref\]                                                   Disease   Study design No. of patients                            Sample collection methods                              Analysis                                     Key findings                                                                                                                                                                                                              Weaknesses                                                             Level evidence
  ----------------------------------------------------------------------------------- --------- ------------------------------------------------------- ------------------------------------------------------ -------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------- -----------------
  **Paulino** ***et al*** **. 2006** [18](#bcp13662-bib-0018){ref-type="ref"}         PV        Case control\                                           Sterile swabs\                                         18S rRNA 5.8S rDNA                           *▪ Malassezia* mycobiota substantially different PV *vs*. HV                                                                                                                                                              *▪* Small cohort                                                       Low
                                                                                                3 PV/5 HV                                               Lesional and nonlesional skin\                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                        Multiple sampling in one PV and 2 HV                                                                                                                                                                                                                                                                                                                                                                 

  **Amaya** ***et al*** **. 2007** [19](#bcp13662-bib-0019){ref-type="ref"}           PV        Case control\                                           OpSite® transparent adhesive dressings\                5.8S rDNA                                    *▪ Malassezia* species detected in overall sites higher in PV and AD compared to HV                                                                                                                                       *▪* Small cohort\                                                      Low
                                                                                                22 PV/36 AD/30 HV                                       Lesional and nonlesional skin                                                                                                                                                                                                                                                                                                 *▪* PV patients on treatment\                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Limited analysis\                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Different skin site collection PV *vs*. AD and HV                  

  **Paulino** ***et al*** **. 2008** [20](#bcp13662-bib-0020){ref-type="ref"}         PV        Case control\                                           Sterile swabs\                                         5.8S rDNA                                    *▪* Mycobiota relatively stable over time.\                                                                                                                                                                               *▪* Small cohort\                                                      Low
                                                                                                1 PV/1 HV                                               Lesional and nonlesional skin\                                                                      *▪* No significant dichotomy between PV and HV.                                                                                                                                                                           *▪* Limited analysis                                                   
                                                                                                                                                        Multiple time points                                                                                                                                                                                                                                                                                                                                                                                 

  **Gao** ***et al*** **. 2008** [21](#bcp13662-bib-0021){ref-type="ref"}             PV        Case control\                                           Sterile swabs\                                         16S rRNA V1‐V9                               *▪* Firmucutes more abundant in lesional skin PV *vs*. nonlesional skin and HV.\                                                                                                                                          *▪* Small cohort\                                                      Low
                                                                                                6 PV/6 HV                                               Lesional and nonlesional skin                                                                       *▪* Actinobacteria less abundant in lesional skin PV *vs*. nonlesional skin and HV.                                                                                                                                       *▪* No serial sampling                                                 

  **Fahlen** ***et al*** **. 2011** [22](#bcp13662-bib-0022){ref-type="ref"}          PV        Case control\                                           2‐mm skin punch biopsies                               16S rRNA V3‐V4                               *▪* Most common phyla in PV and HV: Firmicutis, Proteobacteria, Actinobacteria.\                                                                                                                                          *▪* Small cohort\                                                      Low
                                                                                                10 PV/12 HV                                                                                                                                                 *▪* Staphylococci and Propionibacteria were less common in psoriatic lesions                                                                                                                                              *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Variation in skin sample sites                                     

  **Alekseyenko** ***et al*** **. 2013** [23](#bcp13662-bib-0023){ref-type="ref"}     PV        Case control & Prospective longitudinal cohort study\   Sterile swabs\                                         16S rRNA V1‐V3                               *▪* Most common phyla in PV and HV: Firmicutis, Proteobacteria, Actinobacteria.\                                                                                                                                          *▪* Some patients on active treatment\                                 Low to moderate
                                                                                                CC: 54 PV/37 HV\                                        Lesional and nonlesional skin\                                                                      *▪* Combined relative abundance of *Corynebacterium*, *Streptococcus* and *Staphylococcus* was increased in psoriatic skin, compared to unaffected skin and healthy control skin                                          *▪* Mainly severe patients                                             
                                                                                                PC: 17 PV/15 HV                                         HV matched sites\                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                        Multiple sampling                                                                                                                                                                                                                                                                                                                                                                                    

  **Statnikov** ***et al*** **. 2013** [24](#bcp13662-bib-0024){ref-type="ref"}       PV        Case control\                                           Sterile swabs\                                         16S rRNA V1‐V3 and V3‐V5                     *▪* Microbiome signatures could be used to diagnose psoriasis                                                                                                                                                             *▪* No serial sampling                                                 Low to moderate
                                                                                                54 PV/37 HV                                             Lesional and nonlesional skin\                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                        HV matched sites                                                                                                                                                                                                                                                                                                                                                                                     

  **Takemoto** ***et al*** **. 2015** [25](#bcp13662-bib-0025){ref-type="ref"}        PV        Case control\                                           PV: psoriatic scales by tweezer\                       26S rRNA D1 -- D2                            *▪* Psoriatic lesions exhibited significantly greater diversity compared to HV\                                                                                                                                           *▪* Small cohort\                                                      Low
                                                                                                12 PV/12 HV                                             HV: OpSite® transparent adhesive dressings                                                          *▪ Malassezia restricta* levels were significantly higher in psoriatic lesions, compared to healthy controls                                                                                                              *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Only male patients\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Different sample method PV and HV                                  

  **Salava** ***et al*** **. 2017** [26](#bcp13662-bib-0026){ref-type="ref"}          PV        Case control\                                           Sterile swabs\                                         16S rRNA V1‐V3                               *▪* No significant differences microbial diversity between lesional and nonlesional skin                                                                                                                                  *▪* Small cohort\                                                      Low
                                                                                                13 PV                                                   Lesional and nonlesional skin                                                                                                                                                                                                                                                                                                 *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Variation in skin sample sites                                     

  **Tett** ***et al*** **. 2017** [27](#bcp13662-bib-0027){ref-type="ref"}            PV        Case control\                                           Sterile swabs\                                         WMS sequencing                               *▪* Plaques at the ear had a significant decrease in microbial diversity, and increase in *Staphylococcus* abundance\                                                                                                     *▪* Small cohort\                                                      Low
                                                                                                28 PV                                                   Lesional and nonlesional skin                                                                       *▪* At species level, no differences between lesional and nonlesional skin were observed                                                                                                                                  *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Some patients on active treatment                                  

  **Ring** ***et al*** **. 2017** [28](#bcp13662-bib-0028){ref-type="ref"}            HS        Case control\                                           Biopsies\                                              16S rRNA V3‐V4\                              *▪* Microbiome in HS significantly different from HV in lesional and nonlesional skin\                                                                                                                                    *▪* Small cohort\                                                      Low
                                                                                                30 HS\                                                  Lesional and nonlesional skin                          18S rDNA V3‐V4                               *▪* Five microbiome types identified\                                                                                                                                                                                     *▪* No serial sampling                                                 
                                                                                                24 HV                                                                                                                                                       *▪* Lesional skin consisted predominantly of *Corynebacterium* species (type I) and *Peptoniphilus* species (type IV)\                                                                                                                                                                           
                                                                                                                                                                                                                                                            *▪ Propionibacterium* showed a significant higher abundance in HV                                                                                                                                                                                                                                

  **Guet‐Revillet** ***et al*** **. 2017** [29](#bcp13662-bib-0029){ref-type="ref"}   HS        Prospective cohort\                                     Sterile swabs\                                         16S rRNA\                                    *▪* Lesional skin consisted predominantly of anaerobes (*Porphyromonas* and *Prevotella* species)\                                                                                                                        *▪* Small cohort                                                       Low
                                                                                                65 HS                                                   Lesional and nonlesional skin                          V1‐V2                                        *▪* Clinical severity significantly associated with variations in lesional microbiota\                                                                                                                                                                                                           
                                                                                                                                                                                                                                                            *▪* Fusobacterium associated with severe HS                                                                                                                                                                                                                                                      

  **Dowd** ***et al*** **. 2008** [30](#bcp13662-bib-0030){ref-type="ref"}            UC        Prospective cohort\                                     Debridement samples                                    16S rRNA V4                                  *▪* Major populations include of all wound include: *Staphylococcus*, *Pseudomonas*, *Peptoniphilus*, *Enterobacter*, *Strenotrophomonas*, *Finegoldia* and *Serratia* species\                                           *▪* Small study\                                                       Low
                                                                                                10 VLU/10 DFU/\                                                                                                                                             *▪* Each wound type different profile, dependent on oxygen tolerance of the bacterial population                                                                                                                          *▪* No serial sampling                                                 
                                                                                                10 PU                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  **Price** ***et al*** **. 2009** [31](#bcp13662-bib-0031){ref-type="ref"}           UC        Prospective cohort\                                     Wound base curette\                                    16S rRNA V3                                  *▪* Fastidious anaerobic bacteria of the Clostridiales family XI were the most prevalent bacteria in wounds\                                                                                                              *▪* Small study\                                                       Low
                                                                                                7 DFU/7 NU/3 VLU/3 PSU/4 OTH                            Multiple time points                                                                                *▪* Wound microbiota from antibiotic treated patients were significantly different from untreated patients\                                                                                                               *▪* Sampling time point variable\                                      
                                                                                                                                                                                                                                                            *▪* In diabetic patients, *Streptococcus* was more abundant                                                                                                                                                               *▪* Patients on wide variety of treatments                             

  **Price** ***et al*** **. 2011** [32](#bcp13662-bib-0032){ref-type="ref"}           UC        Cross‐sectional\                                        Wound base curette\                                    16S rRNA V3‐V4                               *▪* The 10 most common genera included *Staphylococcus*, *Pseudomonas*, *Streptococcus*, *Anaerococcus*, *Ralstonia*, *Morganella*, *Porphyromonas*, *Peptoniphilus*, *Janthinobacterium* and *Corynebacterium*\          *▪* Small cohort\                                                      Low
                                                                                                4 DFU/3 NU/3 VLU/2 OTH                                  Multiple samples taken                                                                              *▪* Samples from different sites within individual wounds shared similarities in bacterial community compositions\                                                                                                        *▪* Patients on active treatment\                                      
                                                                                                                                                                                                                                                            *▪* Samples taken from different wounds were less similar than those taken from different sites within the same wound                                                                                                     *▪* No serial sampling                                                 

  **Rhoads** ***et al*** **. 2012** [33](#bcp13662-bib-0033){ref-type="ref"}          UC        Cross‐sectional\                                        Wound base curette                                     16S rRNA V1‐V3                               *▪* The ten most common genera included *Staphylococcus*, *Pseudomonas*, *Streptococcus*, *Anaerococcus*, *Ralstonia*, *Morganella*, *Porphyromonas*, *Peptoniphilus*, *Janthinobacterium* and *Corynebacterium*\         *▪* Small cohort\                                                      Low
                                                                                                4 DFU/3 NU/3 VLU/2 OTH                                                                                                                                      *▪* Samples from different sites within individual wounds shared similarities in bacterial community compositions\                                                                                                        *▪* Patients on active treatment\                                      
                                                                                                                                                                                                                                                            *▪* Samples taken from different wounds were less similar than those taken from different sites within the same wound                                                                                                     *▪* No serial sampling                                                 

  **Gjodsbol** ***et al*** **. 2012** [34](#bcp13662-bib-0034){ref-type="ref"}        UC        Comparative\                                            Filter paper pad & punch biopsies                      16S rRNA V1‐V3                               *▪ Staphylococcus aureus* most found species\                                                                                                                                                                             *▪* No controls                                                        Low
                                                                                                46\                                                                                                                                                         *▪* Multiple sampling over time lead to identification of additional species\                                                                                                                                                                                                                    
                                                                                                VLU                                                                                                                                                         *▪* No difference in outcomes different sample techniques                                                                                                                                                                                                                                        

  **Gardner** ***et al*** **. 2013** [35](#bcp13662-bib-0035){ref-type="ref"}         UC        Cross‐sectional\                                        Sterile swabs                                          16S rRNA V1‐V3                               *▪* The most abundant OTU was *Staphylococcus*, with *S. aureus* the most common species\                                                                                                                                 *▪* No serial sampling\                                                Low
                                                                                                52\                                                                                                                                                         *▪* Ulcer closing was positively correlated with number of species level OTUs, higher microbial diversity, relative abundance of Proteobacteria, and negatively correlated with relative abundance of *Staphylococcus*\   *▪* No controls                                                        
                                                                                                DFU                                                                                                                                                         *▪* Ulcer depth was negatively associated with *Staphylococcus* abundance and positively associated with anaerobic bacteria relative abundance                                                                                                                                                   

  **Wolcott** ***et al*** **. 2016** [37](#bcp13662-bib-0037){ref-type="ref"}         UC        Cohort\                                                 Sharp debridement at surface wound bed                 16S rRNA V1‐V3                               *▪* Neither patient demographics (age, gender, race, diabetes status) nor wound type influenced the bacterial composition of the chronic wound microbiome\                                                                *▪* Unclear whether patients were on treatment                         Low to moderate
                                                                                                2963\                                                                                                                                                       *▪ Staphylococcus* and *Pseudomonas* comprise the most prevalent genera present in the microbiota of chronic wounds, with *S. aureus* and *S. epidermidis* the most predominant species\                                                                                                         
                                                                                                910 DFU/916 VLU/676 DU/370 PSU                                                                                                                              *▪* Chronic wounds are frequently colonized by communalistic and anaerobic bacteria, including coagulation‐negative *Staphylococcus*, *Corynebacterium*, and *Propionibacterium* species                                                                                                         

  **Smith** ***et al*** **. 2016** [36](#bcp13662-bib-0036){ref-type="ref"}           UC        Cohort\                                                 Sterile swabs                                          16S rRNA V4                                  *▪* The most commonly detected bacteria in all ulcers were *Peptoniphilus*, *Anaerococcus* and *Corynebacterium* species\                                                                                                 *▪* Small cohort\                                                      Low
                                                                                                20 DFU                                                                                                                                                      *▪* In new ulcers, the most commonly detected bacteria were the above and *Staphylococcus* species\                                                                                                                       *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                            *▪* The majority of OTUs residing in both new and recurrent ulcers (\>67%) were mostly Gram‐positive cocci (*Staphylococcus*, *Streptococcus*, *Anaerococcus*, *Peptoniphilus* and *Finegoldia*\                          *▪* No controls                                                        
                                                                                                                                                                                                                                                            *▪* Lower HbA1c values and shorter duration of diabetes correlated with higher diversity within the ulcer                                                                                                                                                                                        

  **Kalan** ***et al*** **. 2016** [38](#bcp13662-bib-0038){ref-type="ref"}           UC        Prospective longitudinal cohort\                        Sterile swabs\                                         ITS1 rRNA                                    *▪* Fungal microbiome was highly heterogeneous over time and between subjects\                                                                                                                                            *▪* No controls\                                                       Low to moderate
                                                                                                100 DFU                                                 Multiple time point sampling                                                                        *▪* Fungal diversity increased with antibiotic administration\                                                                                                                                                            *▪* Most patients on active treatment                                  
                                                                                                                                                                                                                                                            *▪* The proportion of the phylum Ascomycota were significantly greater at the beginning of the study in wounds that took \>8 weeks to heal                                                                                                                                                       

  **Loesche** ***et al*** **. 2017** [39](#bcp13662-bib-0039){ref-type="ref"}         UC        Prospective longitudinal cohort\                        Sterile swabs\                                         16S rRNA V1‐V3                               *▪* The most abundant genus identified was *Staphylococcus*, followed by *Streptococcus*, *Corynebacterium* and *Anaerococcus*\                                                                                           *▪* No controls\                                                       Low to moderate
                                                                                                100 DFU                                                 Multiple time point sampling                                                                        *▪* The major OTU attributed to *Staphylococcus* was S. *aureus*\                                                                                                                                                         *▪* Most patients on active treatment                                  
                                                                                                                                                                                                                                                            *▪* Ulcer microbiota was highly dynamic, with community type transitions occurring approximately every 3.52 weeks\                                                                                                                                                                               
                                                                                                                                                                                                                                                            *▪* Microbiota community instability was associated with faster healing and improved outcomes\                                                                                                                                                                                                   
                                                                                                                                                                                                                                                            *▪* Exposure to systemic antibiotics destabilize wound microbiota, rather than altering overall diversity or relative abundance of specific taxa                                                                                                                                                 

  **Kuk Park** ***et al*** **. 2012** [40](#bcp13662-bib-0040){ref-type="ref"}        SD/PC     Case control\                                           Sterile swabs                                          26S rRNA D1‐D2                               *▪ P. meleagrinum* and *P. chrusogenum* detected on dandruff scalp\                                                                                                                                                       *▪* Small cohort\                                                      Low
                                                                                                4 PC\                                                                                                                                                       *▪ Malassezia* spp. 2 times more abundant on dandruff scalp                                                                                                                                                               *▪* No serial sampling                                                 
                                                                                                3 HV                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  **Clavaud** ***et al*** **. 2013.** [41](#bcp13662-bib-0041){ref-type="ref"}        SD/PC     Case--control\                                          Sterile swabs\                                         16S\                                         *▪ M. restricta* major fungal species on scalp PC and HV\                                                                                                                                                                 *▪* Small cohort\                                                      Low
                                                                                                29 PC\                                                  In 20 PC patients lesional and nonlesional sampling    28S‐ITS                                      *▪ M. restricta and s. epidermidis* significantly more abundant on PC scalp\                                                                                                                                              *▪* No serial sampling                                                 
                                                                                                20 HV                                                                                                                                                       *▪ Propionibacterium acnes* significantly less abundant on PC scalp\                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                            *▪ M. restricta/P. acnes* ratio significantly higher in PC scalp                                                                                                                                                                                                                                 

  **Soares** ***et al*** **. 2015** [42](#bcp13662-bib-0042){ref-type="ref"}          SD/PC     Case control\                                           Sterile swabs\                                         5.8S/ITS2 rDNA                               *▪* In general, no association between *Malassezia* mycobiota and SD was found\                                                                                                                                           *▪* Small cohort\                                                      Low
                                                                                                9 SD (5 mild, 4 severe)\                                Scalp, forehead chin, shoulder and interface samples                                                *▪* Higher *m. globosa* abundance was found in nonscalp lesions of severe SD patients                                                                                                                                     *▪* No serial sampling                                                 
                                                                                                5 HV                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  **Park** ***et al*** **. 2017** [43](#bcp13662-bib-0043){ref-type="ref"}            SD/PC     Case control\                                           Sterile swabs\                                         16 s rRNA V4‐V5\                             *▪* Higher abundance of *Staphylococcus* sp. and *m. restricta*, and lower abundance of *Propionibacterium* associated with scalp disease                                                                                 *▪* No serial sampling                                                 Low
                                                                                                29 SD\                                                  Scalp samples                                          ITS1 rDNA                                                                                                                                                                                                                                                                                                                                     
                                                                                                28 PC\                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                45 HV                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  **Bek‐Thomsen** ***et al*** **. 2008** [44](#bcp13662-bib-0044){ref-type="ref"}     AV        Case control\                                           Cyanoacrylate biopsy\                                  16S rRNA V1‐V9                               *▪* Acne skin higher diversity, *P. acnes* and *S. epidermidis* most common species                                                                                                                                       *▪* Small cohort\                                                      Low
                                                                                                5 AV/3 HV                                               AV acne lesion face\                                                                                                                                                                                                                                                                                                          *▪* Only moderate to severe patients\                                  
                                                                                                                                                        HV nose area                                                                                                                                                                                                                                                                                                                  *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* No nonlesional patient sampling                                    

  **Fitz‐Gibbon** ***et al*** **. 2013** [45](#bcp13662-bib-0045){ref-type="ref"}     AV        Case control\                                           Bioré® Deep Cleansing Pore strips\                     16S rRNA V1‐V9                               *▪* No difference relative abundance *P. acnes* AV in HV.\                                                                                                                                                                *▪* Some patients on active treatment\                                 Low
                                                                                                49 AV/52 HV                                             Nose area                                                                                           *▪* Association specific *P. acnes* strain and acne.                                                                                                                                                                      *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* No nonlesional patient sampling                                    

  **Barnard** ***et al*** **. 2016** [46](#bcp13662-bib-0046){ref-type="ref"}         AV        Case control\                                           Bioré® Deep Cleansing Pore strips\                     WMS sequencing                               *▪* Association specific *P. acnes* strain and acne.                                                                                                                                                                      *▪* Some patients on active treatment\                                 Low
                                                                                                38 AV/34 HV                                             Nose area                                                                                                                                                                                                                                                                                                                     *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* No nonlesional patient sampling                                    

  **Dreno** ***et al*** **. 2017** [47](#bcp13662-bib-0047){ref-type="ref"}           AV        Single‐center, randomized‐controlled, double‐blind\     Sterile swabs\                                         16S rRNA V4                                  *▪* Different microbiota profiles on different sites.\                                                                                                                                                                    *▪* Small cohort\                                                      Moderate
                                                                                                Erythromycin 4%\                                        Lesional and nonlesional skin\                                                                      *▪* Erythromycin treatment reduced the number of Actinobacteria, and dermocosmetic reduced Actinobacteria and *Staphylococcus* spp.                                                                                       *▪* Multiple samples excluded due to insufficient bacterial material   
                                                                                                OR\                                                     Multiple time points                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                Dermatocosmetic\                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                26 AV                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  **Kelhala** ***et al*** **. 2017** [48](#bcp13662-bib-0048){ref-type="ref"}         AV        Single‐centre, controlled study\                        Sterile swabs\                                         16S rRNA V1‐V3                               *▪* Positive correlation *Propionibacterium* abundance and acne severity grade\                                                                                                                                           *▪* Small cohort\                                                      Moderate
                                                                                                isotretinoin 0.4--0.6 mg kg^--1^\                       Predose and after 6 weeks\                                                                          *▪* Both treatments reduced clinical acne grades\                                                                                                                                                                         *▪* No nonlesional patient sampling                                    
                                                                                                or\                                                     Cheek, back and armpit                                                                              *▪ Propionibacterium* decreased in cheek samples after both treatments\                                                                                                                                                                                                                          
                                                                                                lymecycline 300 mg twice daily\                                                                                                                             *▪ Propionibacterium* decreased in back samples after lymecycline, but not isotretinoin treatment\                                                                                                                                                                                               
                                                                                                17 isotretinoin\                                                                                                                                            *▪* Diversity increased after treatment                                                                                                                                                                                                                                                          
                                                                                                11 lymecycline\                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                16 HV                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  **Sugita** ***et al*** **. 2004** [58](#bcp13662-bib-0058){ref-type="ref"}          AD        Case control\                                           OpSite® transparent adhesive dressings\                26S and 5S rRNA intergenic spacer region 1   *▪ M. restricta* colonizes both AD and HV                                                                                                                                                                                 *▪* Small cohort\                                                      Low
                                                                                                13 AD/12 HV                                             Lesional skin\                                                                                                                                                                                                                                                                                                                *▪* No serial sampling\                                                
                                                                                                                                                        HV matched sites                                                                                                                                                                                                                                                                                                              *▪* Limited analysis\                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Patients on active treatment                                       

  **Dekio** ***et al*** **. 2007** [49](#bcp13662-bib-0049){ref-type="ref"}           AD        Case control\                                           Sterile swabs\                                         16S rRNA                                     *▪* In both AD and HV there was a high rate of *Streptococcus* species\                                                                                                                                                   *▪* Small cohort\                                                      Low
                                                                                                13 AD/10 HV                                             Forehead skin                                                                                       *▪* In AD *Strenotrophomonas maltophilia* was significantly more common                                                                                                                                                   *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Patients on active treatment                                       

  **Kaga** ***et al***. **2009** [50](#bcp13662-bib-0050){ref-type="ref"}             AD        Case control\                                           OpSite® transparent adhesive dressings\                26S and 5S rRNA intergenic spacer region 1   *▪* In mild and moderate AD, *M. restricta* was predominant over *M. globose*\                                                                                                                                            *▪* Limited analysis\                                                  Low to moderate
                                                                                                56 AD/32 HV                                             Lesional skin AD\                                                                                   *▪* In patients with severe AD, proportions of *M. restricta* and *M. globose* were almost identical                                                                                                                      *▪* No serial sampling\                                                
                                                                                                                                                        Face HV                                                                                                                                                                                                                                                                                                                       *▪* Variation in skin sample sites\                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* Patients possibly on active treatment                              

  **Yim** ***et al*** **. 2010** [51](#bcp13662-bib-0051){ref-type="ref"}             AD        Prospective cohort\                                     Sterile swabs\                                         26S                                          *▪* There were no significant differences between positive *Malassezia* culture, *Malassezia* species, and severity of AD                                                                                                 *▪* Limited analysis\                                                  Low to moderate
                                                                                                60                                                      5 body sites                                                                                                                                                                                                                                                                                                                  *▪* Patients on emollient treatment                                    

  **Akaza** ***et al*** **. 2010** [52](#bcp13662-bib-0052){ref-type="ref"}           AD        Case control\                                           Sterile swabs\                                         26S                                          *▪* For the total number of *Malassezia* species, there were no significant differences between lesional and nonlesional areas                                                                                            *▪* No serial sampling\                                                Low to moderate
                                                                                                67                                                      Lesional and nonlesional skin\                                                                                                                                                                                                                                                                                                *▪* Patients on active treatment                                       
                                                                                                                                                        Face and trunk                                                                                                                                                                                                                                                                                                                                                                                       

  **Kong** ***et al*** **. 2012** [60](#bcp13662-bib-0060){ref-type="ref"}            AD        Prospective cohort\                                     Sterile swabs\                                         16S rRNA V1‐V9                               *▪* Flare ups were associated with an increased proportion of *Staphylococcus* sequences, particularly *S. aureus*, and correlated with disease severity\                                                                 *▪* Small cohort\                                                      Low to moderate
                                                                                                12 AD/11 HV                                             Multiple time points\                                                                               *▪* Increases in *Streptococcus*, *Propionbacterium*, and *Corynebacterium* species were observed following therapy                                                                                                       *▪* Only moderate to severe patients\                                  
                                                                                                                                                        Baseline, flare, post‐flare                                                                                                                                                                                                                                                                                                   *▪* Different treatments regimens during flare                         

  **Seite** ***et al*** **. 2014** [54](#bcp13662-bib-0054){ref-type="ref"}           AD        Prospective cohort\                                     Sterile swabs\                                         16S rRNA V1‐V2                               *▪* Affected skin harboured a greater relative abundance of *Staphylococcus*, and in particular *S. epidermis*, compared to healthy skin\                                                                                 *▪* Large time between first and second sample\                        Low to moderate
                                                                                                Emolliens treatment\                                    Lesional and nonlesional skin\                                                                      *▪* Responders had increased microbial diversity and decrease in *Staphylococcus* species                                                                                                                                 *▪* Only moderate patients                                             
                                                                                                46                                                      Multiple time points                                                                                                                                                                                                                                                                                                                                                                                 

  **Chng** ***et al*** **. 2016** [55](#bcp13662-bib-0055){ref-type="ref"}            AD        Case control\                                           Tape stripping anti‐cubital fossa                      16S rRNA V3‐V6\                              *▪* Nonflare, baseline skin microbiome signatures enriched for *Streptococcus* and *Gemella* in AD prone skin versus normal skin\                                                                                         *▪* Small cohort\                                                      Low
                                                                                                19 medical history AD/15 HV/5 positive skin prick                                                              WMS                                          *▪* Increased percentage of *S. aureus* carriers noted in AD cohort over control subjects                                                                                                                                 *▪* No serial sampling\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *▪* No lesional samples                                                

  **Gonzalez** ***et al*** **. 2016** [56](#bcp13662-bib-0056){ref-type="ref"}        AD        Randomized, placebo‐controlled, single‐blinded\         Sterile swabs\                                         16S rRNA V4                                  *▪* Affected skin harboured a greater relative abundance of *S. aureus*\                                                                                                                                                  *▪* Small study                                                        Moderate
                                                                                                Topical steroid\                                        Lesional and nonlesional skin\                                                                      *▪* Microbial diversity at all lesional sites inversely correlated with overall EASI Index score\                                                                                                                                                                                                
                                                                                                or\                                                     Multiple time points                                                                                *▪* Taxonomic normalization occurred on lesional following treatments\                                                                                                                                                                                                                           
                                                                                                Topical steroid + dilute bleach bath\                                                                                                                       *▪* Bacterial communities on lesional skin resemble nonlesional skin but remain distinct from healthy control skin                                                                                                                                                                               
                                                                                                21 AD/14 HV                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  **Seite** ***et al*** **. 2017** [57](#bcp13662-bib-0057){ref-type="ref"}           AD        Double‐blind, Randomized, comparative\                  Sterile swabs\                                         16S rRNA V1‐V2                               *▪* Significant increased levels of *Xanthomonas* genus in patients treated with emollient A\                                                                                                                             *▪* Only moderate patients\                                            Moderate
                                                                                                Emollient A\                                            Lesional and nonlesional skin\                                                                      *▪* Levels of *Staphylococcus* genus increased between Day 1 and Day 28 in patients treated with emollient B                                                                                                              *▪* No wash‐out other treatments                                       
                                                                                                or\                                                     Multiple time points                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                Emollient B\                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                53                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  **Kim** ***et al*** **. 2017** [59](#bcp13662-bib-0059){ref-type="ref"}             AD        Prospective cohort\                                     Saline soaked gauzes                                   16S rRNA V1‐V3                               *▪* Proportion of *Staphylococcus* significantly decreased after treatment\                                                                                                                                               *▪* Small study\                                                       Low to moderate
                                                                                                Wet dressings\                                                                                                                                              *▪* Diversity (Shannon Index) significantly increased after treatment                                                                                                                                                     *▪* Patients on wide variety of treatments\                            
                                                                                                Topical steroids\                                                                                                                                                                                                                                                                                                                                                                     *▪* No nonlesional skin analysis                                       
                                                                                                Antihistamines\                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                Antibiotics\                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                27 AD\                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                6 HV                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AD, atopic dermatitis; AV, acne vulgaris; DFU, diabetic foot ulcer; HS, hidradenitis suppurativa; NU, neuropathic ulcer; OTH, other; OTU, operational taxonomic unit; PSU, post‐surgical ulcer; PU, pressure ulcer; PV, psoriasis vulgaris; SD/PC, seborrhoeic dermatitis/pityriasis capitis; UC, ulcus cruris; VLU, venous leg ulcer

Psoriasis vulgaris {#bcp13662-sec-0008}
------------------

In 10 studies, the cutaneous microbiome in PV patients was investigated, Table [1](#bcp13662-tbl-0001){ref-type="table"} [25](#bcp13662-bib-0025){ref-type="ref"}, [26](#bcp13662-bib-0026){ref-type="ref"}, [27](#bcp13662-bib-0027){ref-type="ref"}, [28](#bcp13662-bib-0028){ref-type="ref"}, [29](#bcp13662-bib-0029){ref-type="ref"}, [30](#bcp13662-bib-0030){ref-type="ref"}, [31](#bcp13662-bib-0031){ref-type="ref"}, [32](#bcp13662-bib-0032){ref-type="ref"}, [33](#bcp13662-bib-0033){ref-type="ref"}, [34](#bcp13662-bib-0034){ref-type="ref"}. In addition to microbiota, these studies have focused on the mycobiota. An increased diversity in the fungal flora in psoriatic skin lesions, compared to healthy skin was reported by Paulino *et al*. [25](#bcp13662-bib-0025){ref-type="ref"} and Amaya *et al*. [26](#bcp13662-bib-0026){ref-type="ref"}. No differences in the abundance of specific species was observed. Controversially, a significant dichotomy between the relative abundances of specific *Malassezia* species between healthy skin, and psoriatic skin lesions was found by Takemoto *et al*. [32](#bcp13662-bib-0032){ref-type="ref"}. Similar inconsistencies in findings were also observed in those studies assessing the microbiota [28](#bcp13662-bib-0028){ref-type="ref"}, [29](#bcp13662-bib-0029){ref-type="ref"}, [30](#bcp13662-bib-0030){ref-type="ref"}, [31](#bcp13662-bib-0031){ref-type="ref"}, [34](#bcp13662-bib-0034){ref-type="ref"}.

Hidradenitis suppurativa {#bcp13662-sec-0009}
------------------------

To date, only two studies have been published that investigated the skin microbiome in HS (Table [1](#bcp13662-tbl-0001){ref-type="table"}) [35](#bcp13662-bib-0035){ref-type="ref"}, [36](#bcp13662-bib-0036){ref-type="ref"}. Both studies report a significant dysbiosis in HS lesional skin with more abundance of anaerobic genera. Five lesional microbiome types were identified of which type 1 (*Corynebacterium* species*)* and type IV (*Porphyromonas* and *Peptoniphilus* species) were most prevalent [35](#bcp13662-bib-0035){ref-type="ref"}. *Porphyromonas* was also found as predominantly abundant on lesional skin by Guet‐Revillet *et al*. [36](#bcp13662-bib-0036){ref-type="ref"}, together with *Prevotella* species. In addition, clinical severity significantly correlated with *Fusobacterium* and *Parvimonas* species variation in this study.

Ulcus cruris {#bcp13662-sec-0010}
------------

The role of the skin microbiome in UC was explored in 10 different studies, Table [1](#bcp13662-tbl-0001){ref-type="table"} [37](#bcp13662-bib-0037){ref-type="ref"}, [38](#bcp13662-bib-0038){ref-type="ref"}, [39](#bcp13662-bib-0039){ref-type="ref"}, [40](#bcp13662-bib-0040){ref-type="ref"}, [41](#bcp13662-bib-0041){ref-type="ref"}, [42](#bcp13662-bib-0042){ref-type="ref"}, [43](#bcp13662-bib-0043){ref-type="ref"}, [44](#bcp13662-bib-0044){ref-type="ref"}, [45](#bcp13662-bib-0045){ref-type="ref"}, [46](#bcp13662-bib-0046){ref-type="ref"}. Current research into UC microbiome, comprises larger, longitudinal studies, compared to those in PV and HS. The skin mycobiota of diabetic foot ulcers was longitudinally assessed and was observed to be highly heterogeneous over time and between subjects while the diversity increased upon antibiotic treatment [45](#bcp13662-bib-0045){ref-type="ref"}. There have been similar efforts to reveal correlations between patient metadata, treatment and/or clinical outcomes and the cutaneous microbiome in studies investigating the microbiota in UC [38](#bcp13662-bib-0038){ref-type="ref"}, [42](#bcp13662-bib-0042){ref-type="ref"}, [43](#bcp13662-bib-0043){ref-type="ref"}, [44](#bcp13662-bib-0044){ref-type="ref"}, [46](#bcp13662-bib-0046){ref-type="ref"}. Overall, the most common found genus in these studies was *Staphylococcus*, with *Staphylococcus aureus* the most common species. Ulcer closing in diabetic patients was found to be positively correlated with higher microbial diversity and relative abundance of *Proteobacteria*, while a relative abundance of *Staphylococcus* was correlated negatively in a study by Gardner *et al*. [42](#bcp13662-bib-0042){ref-type="ref"}. Although *Staphylococcus* was consistently reported to be the most common genus, inconsistencies exist regarding other genus that are important in CU.

Seborrheic dermatitis/Pityriasis capitis {#bcp13662-sec-0011}
----------------------------------------

Four case--control studies investigated the microbiome in SD patients [47](#bcp13662-bib-0047){ref-type="ref"}, [48](#bcp13662-bib-0048){ref-type="ref"}, [49](#bcp13662-bib-0049){ref-type="ref"}, [50](#bcp13662-bib-0050){ref-type="ref"}, Table [1](#bcp13662-tbl-0001){ref-type="table"}. In general, *Malassezia* spp. were found to be more abundant on dandruff scalp compared to healthy scalp [47](#bcp13662-bib-0047){ref-type="ref"}, [48](#bcp13662-bib-0048){ref-type="ref"}, [50](#bcp13662-bib-0050){ref-type="ref"}. In addition to the mycobiota, a dysbiosis in *Staphylococcus* and *Propionibacterium* spp. was described in microbiota analysis [48](#bcp13662-bib-0048){ref-type="ref"}, [50](#bcp13662-bib-0050){ref-type="ref"}. One of the four studies did not find a general association between *Malassezia* spp. and SD but did find a higher abundance of *M. globate* in severe SD patients [49](#bcp13662-bib-0049){ref-type="ref"}.

Acne vulgaris {#bcp13662-sec-0012}
-------------

Five studies investigated the skin microbiome in patients with AV, Table [1](#bcp13662-tbl-0001){ref-type="table"} [51](#bcp13662-bib-0051){ref-type="ref"}, [52](#bcp13662-bib-0052){ref-type="ref"}, [53](#bcp13662-bib-0053){ref-type="ref"}, [54](#bcp13662-bib-0054){ref-type="ref"}, [55](#bcp13662-bib-0055){ref-type="ref"}. Three (3) were case--control studies and two (2) were small single‐centre, controlled studies, of whom one was a double‐blind, randomized‐controlled trial. In general, all case--control studies demonstrated similarly an increased microbial abundance of *Propionibacterium acnes* in the skin microbiome of patients with AV, compared to healthy [51](#bcp13662-bib-0051){ref-type="ref"}, [52](#bcp13662-bib-0052){ref-type="ref"}, [53](#bcp13662-bib-0053){ref-type="ref"}. In addition, an association between a specific *P. acnes* strains and acne affected skin, and healthy skin respectively was demonstrated [51](#bcp13662-bib-0051){ref-type="ref"}, [52](#bcp13662-bib-0052){ref-type="ref"}. Acne improved and *Propionibacterium* abundance decreased after various treatments, together with an increase of microbial diversity in the two controlled studies. Moreover, a positive correlation between *Propionibacterium* abundance and acne severity grade was found [54](#bcp13662-bib-0054){ref-type="ref"}, [55](#bcp13662-bib-0055){ref-type="ref"}.

Atopic dermatitis {#bcp13662-sec-0013}
-----------------

The skin microbiome in patients with AD was assessed in 11 studies, Table [1](#bcp13662-tbl-0001){ref-type="table"} [56](#bcp13662-bib-0056){ref-type="ref"}, [57](#bcp13662-bib-0057){ref-type="ref"}, [58](#bcp13662-bib-0058){ref-type="ref"}, [59](#bcp13662-bib-0059){ref-type="ref"}, [60](#bcp13662-bib-0060){ref-type="ref"}, [61](#bcp13662-bib-0061){ref-type="ref"}, [62](#bcp13662-bib-0062){ref-type="ref"}, [63](#bcp13662-bib-0063){ref-type="ref"}, [64](#bcp13662-bib-0064){ref-type="ref"}, [65](#bcp13662-bib-0065){ref-type="ref"}, [66](#bcp13662-bib-0066){ref-type="ref"}. A greater proportion of longitudinal studies and 2 completed randomized controlled trials were performed in AD patients. There is general consensus across studies that skin affected by AD exhibits decreased bacterial diversity, as a result of an increased abundance of *S. aureus* [60](#bcp13662-bib-0060){ref-type="ref"}, [61](#bcp13662-bib-0061){ref-type="ref"}, [62](#bcp13662-bib-0062){ref-type="ref"}, [63](#bcp13662-bib-0063){ref-type="ref"}, [64](#bcp13662-bib-0064){ref-type="ref"}, [66](#bcp13662-bib-0066){ref-type="ref"}. In particular, AD flare ups were associated with an increased proportion of *Staphyloccocus* sequences, and *S. aureus* abundance correlated with disease severity [60](#bcp13662-bib-0060){ref-type="ref"}. In line with these results, microbial diversity in AD lesions was inversely correlated with overall eczema severity as observed by the EASI [63](#bcp13662-bib-0063){ref-type="ref"}, with several further studies also reporting taxonomic normalization and increased bacterial diversity in AD lesional skin, following various treatments [60](#bcp13662-bib-0060){ref-type="ref"}, [61](#bcp13662-bib-0061){ref-type="ref"}, [63](#bcp13662-bib-0063){ref-type="ref"}, [66](#bcp13662-bib-0066){ref-type="ref"}.

Discussion {#bcp13662-sec-0014}
==========

This systematic review provides an overview of the clinical studies that have investigated nonculture skin microbiome associated outcomes in AD, SD, AV, HS, PV and UC with the goal to explore its potential as biomarker in early phase clinical drug development with drug specific or disease specific application, as also referred to as type 3 or type 6 biomarker according to the classic definition of Danhof *et al*. [67](#bcp13662-bib-0067){ref-type="ref"}.

Potential for microbiome as biomarker: AD and AV {#bcp13662-sec-0015}
------------------------------------------------

From our analysis, there is some preliminary evidence that the skin microbiota may be a suitable disease specific biomarker for clinical trials of AD. This is due to the correlation between *Staphylococcus* abundance, microbiome diversity profile and disease severity that seems to exist in multiple trials, therewith complying with most of the criteria for a useful biomarker, Table [2](#bcp13662-tbl-0002){ref-type="table"} [4](#bcp13662-bib-0004){ref-type="ref"}. Objective data on the change of the microbiota may be valuable to support subjective AD efficacy scores in early phase clinical trials. However, it must be noted that the cause and effect relationship between skin microbiota dysbiosis and AD remains incompletely elucidated [68](#bcp13662-bib-0068){ref-type="ref"}. Currently, no evidence of benefit of antimicrobial interventions directed at reduction of *Staphylococcus* in patients with AD exists, only in secondarily impetiginized AD [69](#bcp13662-bib-0069){ref-type="ref"}, [70](#bcp13662-bib-0070){ref-type="ref"}, [71](#bcp13662-bib-0071){ref-type="ref"}. As multiple studies included in this review indicate that the skin microbiota within an individual patient varies over time [60](#bcp13662-bib-0060){ref-type="ref"}, [61](#bcp13662-bib-0061){ref-type="ref"}, [63](#bcp13662-bib-0063){ref-type="ref"}, [64](#bcp13662-bib-0064){ref-type="ref"}, there is need for longitudinal, frequent sampling and standard analysis studies. Nevertheless, it has proven its potential value and is recommended to apply in AD clinical trials, in particular when microbiota can serve also as drug‐specific biomarker, i.e. for drugs with antimicrobial activity such as antimicrobial peptides that are currently in clinical trials for AD.

###### 

Evaluation of the microbiome as clinical biomarker for each dermatological disease included in the review based on the criteria of a useful biomarker as defined by de Visser *et al*. [4](#bcp13662-bib-0004){ref-type="ref"}

  Indication   Manuscripts (N)   Evidence level overall   Consistency   Therapeutic response   Dose--response relation   Relationship with disease   Recommendation for trial implementation
  ------------ ----------------- ------------------------ ------------- ---------------------- ------------------------- --------------------------- -----------------------------------------
  **PV**       10                Low                      --            0                      0                         0                           Negative, more evidence needed
  **HS**       2                 Low                      \+            0                      0                         \+                          Negative, more evidence needed
  **UC**       10                Low                      \+            0                      0                         \+                          Negative, more evidence needed
  **SD**       4                 Low                      --            0                      0                         \+                          Negative, more evidence needed
  **AV**       5                 Moderate                 \+            \+                     0                         \+                          Positive
  **AD**       11                Moderate                 \+            \+                     0                         \+                          Positive

AD, atopic dermatitis; AV, acne vulgaris; HS, hidradenitis suppurativa; PV, psoriasis vulgaris; SD/PC, seborrhoeic dermatitis/pityriasis capitis; UC, ulcus cruris

Scoring system indicated as follows: +, studies in general report a positive outcome; 0, no studies available; --, studies in general report a negative outcome

In AV, a strong, positive correlation between *Propionibacterium* and acne severity grade is reported [55](#bcp13662-bib-0055){ref-type="ref"}. Moreover, acne improved and *Propionibacterium* decreased after treatment, while the microbial diversity increased [54](#bcp13662-bib-0054){ref-type="ref"}, [55](#bcp13662-bib-0055){ref-type="ref"}. Taking into account that a clear pathophysiological role of *P. acnes* exists and antimicrobial interventions are effective in AV [72](#bcp13662-bib-0072){ref-type="ref"}, [73](#bcp13662-bib-0073){ref-type="ref"}, the adoption of the skin microbiome as biomarker in acne drug development programmes is, although still in its infancy, suggested by our review (Table [2](#bcp13662-tbl-0002){ref-type="table"}). Lesion clearance often takes a long time; therefore, the inclusion of microbiota is a valid option to monitor subclinical treatment effects and restoration of normal bacterial profile, i.e. rebiosis. Although a small uncertainty remains regarding the exact relationship between aberrations in the skin microbiome and acne [74](#bcp13662-bib-0074){ref-type="ref"}, we conclude that there is definitely a potential for the microbiota as biomarker in clinical trials (Table [2](#bcp13662-tbl-0002){ref-type="table"}). Another option would be to culture *P. acnes* instead of profiling the whole skin microbiota in clinical trials; however, with this approach a comprehensive overview and insight in the diversity will be missed.

PV, UC, hidradenitis and SD are lacking evidence {#bcp13662-sec-0016}
------------------------------------------------

Although dysbiosis in psoriasis seems to exist in the micro‐ as well as the mycobiota, study findings are heterogeneous. Wide variability in study design, sampling methods, controllable factors and sequencing techniques between groups, in conjunction with small sample populations, could provide a possible explanation for this. Therefore, no clear recommendations can be made at this time. Future work focusing on serial sampling and longitudinal studying of skin microbiome populations it PV patients, may provide information on its potential applicability as biomarker, Table [2](#bcp13662-tbl-0002){ref-type="table"}. From a clinical perspective, we know that antimicrobial and antifungal agents are not successful in the treatment of psoriasis, which suggests that it is less attractive to explore [75](#bcp13662-bib-0075){ref-type="ref"}, [76](#bcp13662-bib-0076){ref-type="ref"}. However, since immune dysregulation is the key of psoriasis and recent investigations describe the extensive cross talk between the immune system and the microbiome, there may still be potential that should be explored [77](#bcp13662-bib-0077){ref-type="ref"}. For UC inconsistencies in study design, sampling methods and the heterogeneity of the disease group also limit the comparability of study findings. There appears to be a relationship between certain species, types of ulcers and ulcer duration [42](#bcp13662-bib-0042){ref-type="ref"}, [46](#bcp13662-bib-0046){ref-type="ref"}. However, longitudinal studies with frequent standard sampling and standard analysis procedures are necessary to make a recommendation. The finding of dysbiosis in HS skin microbiome mostly regarding anaerobic species that is mostly consistent in two different studies opens up opportunities for the skin microbiome as biomarker in this field, Table [2](#bcp13662-tbl-0002){ref-type="table"} [35](#bcp13662-bib-0035){ref-type="ref"}, [36](#bcp13662-bib-0036){ref-type="ref"}. However, future studies will have to confirm this potential. In SD, three different sequencing methods were used in the three different studies [47](#bcp13662-bib-0047){ref-type="ref"}, [49](#bcp13662-bib-0049){ref-type="ref"}, [50](#bcp13662-bib-0050){ref-type="ref"}. This, together with the small sample populations, single time point sampling and poor study designs, might explain the heterogeneity in findings. Since there is a clear evidence that antifungal agents such as ketoconazole are effective in SD [78](#bcp13662-bib-0078){ref-type="ref"}, it is recommended to further explore the skin microbiome\'s potential in this disease in future clinical trials.

Limitations and considerations {#bcp13662-sec-0017}
------------------------------

It is important to note that in all included studies, there was a high variability in study design and sampling methods between groups, which makes comparisons of specific findings difficult. Case--control studies (25/42, 60%) dominate research into the skin microbiome and skin disease. Patients are compared with healthy controls, capturing microbial profiles at a particular time, but have little predictive value in determining functionality, looking more at associations, and not causation. The small patient sample sizes across all studies may fail to account for interindividual differences within the study population. The poorly defined inclusion and exclusion criteria, with certain studies including actively treated patients in their sample population, could also confound potential findings. The standardization of controllable factors to reduce confounders was not well documented or maybe not performed in most of the included studies. As simple factors including but not limiting of age, ethnicity, environmental factors, soap use, hand‐washing and the use of topical (antimicrobial) agents before sampling have been shown to alter microbial skin communities; documentation of these metadata is essential to draw valid conclusions [5](#bcp13662-bib-0005){ref-type="ref"}, [8](#bcp13662-bib-0008){ref-type="ref"}, [12](#bcp13662-bib-0012){ref-type="ref"}, [60](#bcp13662-bib-0060){ref-type="ref"}, [61](#bcp13662-bib-0061){ref-type="ref"}, [79](#bcp13662-bib-0079){ref-type="ref"}, [80](#bcp13662-bib-0080){ref-type="ref"}, [81](#bcp13662-bib-0081){ref-type="ref"}. Multiple methods were used for skin microbiome sampling across the studies (i.e. swabs, biopsies, tape strips, wound curettes). Interestingly, all have been shown to exhibit a wide variation in biomass yield, microbial profile, human DNA contribution/contamination, sampling depth and discomfort level for the test subject [19](#bcp13662-bib-0019){ref-type="ref"}, [62](#bcp13662-bib-0062){ref-type="ref"}, [82](#bcp13662-bib-0082){ref-type="ref"}, [83](#bcp13662-bib-0083){ref-type="ref"}, [84](#bcp13662-bib-0084){ref-type="ref"}, [85](#bcp13662-bib-0085){ref-type="ref"}, [86](#bcp13662-bib-0086){ref-type="ref"}, [87](#bcp13662-bib-0087){ref-type="ref"}. In addition to the sampling method, the selection of sampling sites and sampling frequency are important factors that were not always considered in the included studies. Consistent sampling of the same anatomical area of skin in all individuals in study cohorts is essential in order to limit confounders, and allow for the accurate comparison of skin microbiome populations. Moreover, regarding analysis, only consistent use of specific primers to target specific hypervariable V regions, will allow for collation of data and comparison between multiple studies. It is clear that broadly used analysis methods in this review as shown in Table [1](#bcp13662-tbl-0001){ref-type="table"} count as a limitation for comparison. Taken all the above together, based on the level of evidence it is clear that our recommendations should be made with some caution. A standard approach for skin microbiome study design, collection, storage, processing and analysis as proposed by Kong *et al*. should be followed in future studies [17](#bcp13662-bib-0017){ref-type="ref"}. However, although the list of limitations and sometimes poor evidence might be assessed as a weak recommendation for the inclusion of cutaneous microbiome in dermatological trials, the recent finding that the gut microbiome partially explains the response/nonresponse to PD‐1 immunotherapy in different cancer patients will foster research into microbiome in general [88](#bcp13662-bib-0088){ref-type="ref"}, [89](#bcp13662-bib-0089){ref-type="ref"}. In addition, the relation between the gut microbiome in inflammatory bowel disease and response to infliximab was also recently highlighted [90](#bcp13662-bib-0090){ref-type="ref"}. In particular, when considering the reports about the role of the gut‐skin axis that might influence many diseases including the here investigated skin disorders [91](#bcp13662-bib-0091){ref-type="ref"}, [92](#bcp13662-bib-0092){ref-type="ref"}, [93](#bcp13662-bib-0093){ref-type="ref"}.

Conclusion {#bcp13662-sec-0018}
==========

Only a small number of studies have consistently reported the cutaneous microbiome for skin diseases and chronic wounds. Our findings reveal that for two indications -- AD and AV -- there is preliminary evidence to support implementation of the skin microbiome as biomarker in early phase clinical trials. For PV, UC, SD and HS, there is insufficient evidence. More standardized microbiome‐directed studies studying the effect of current treatments on the microbiome are needed to draw conclusions.
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